Campbell & CO Investment Adviser LLC decreased its position in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 16.8% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 17,841 shares of the health services provider's stock after selling 3,615 shares during the period. Campbell & CO Investment Adviser LLC's holdings in Maximus were worth $1,217,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently modified their holdings of MMS. Caitong International Asset Management Co. Ltd raised its holdings in shares of Maximus by 17,533.3% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 529 shares of the health services provider's stock valued at $36,000 after buying an additional 526 shares in the last quarter. UMB Bank n.a. raised its stake in shares of Maximus by 70.2% during the first quarter. UMB Bank n.a. now owns 606 shares of the health services provider's stock worth $41,000 after acquiring an additional 250 shares in the last quarter. GAMMA Investing LLC lifted its holdings in shares of Maximus by 67.1% in the 1st quarter. GAMMA Investing LLC now owns 732 shares of the health services provider's stock worth $50,000 after acquiring an additional 294 shares during the last quarter. NBC Securities Inc. boosted its stake in shares of Maximus by 114,900.0% in the 1st quarter. NBC Securities Inc. now owns 1,150 shares of the health services provider's stock valued at $78,000 after purchasing an additional 1,149 shares in the last quarter. Finally, Blue Trust Inc. grew its holdings in shares of Maximus by 32.8% during the 1st quarter. Blue Trust Inc. now owns 1,228 shares of the health services provider's stock valued at $84,000 after purchasing an additional 303 shares during the last quarter. 97.21% of the stock is currently owned by hedge funds and other institutional investors.
Maximus Stock Up 0.4%
Shares of MMS traded up $0.34 during mid-day trading on Friday, reaching $88.06. The company had a trading volume of 434,573 shares, compared to its average volume of 681,324. Maximus, Inc. has a 52 week low of $63.77 and a 52 week high of $93.94. The company has a debt-to-equity ratio of 0.91, a quick ratio of 2.27 and a current ratio of 2.27. The company has a market capitalization of $4.96 billion, a price-to-earnings ratio of 16.22 and a beta of 0.60. The firm has a 50-day moving average price of $76.35 and a 200 day moving average price of $71.67.
Maximus (NYSE:MMS - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The health services provider reported $2.16 earnings per share for the quarter, topping analysts' consensus estimates of $1.39 by $0.77. The company had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.29 billion. Maximus had a net margin of 5.83% and a return on equity of 24.44%. The firm's revenue for the quarter was up 2.5% on a year-over-year basis. During the same period in the previous year, the business earned $1.74 EPS. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. On average, sell-side analysts forecast that Maximus, Inc. will post 6.15 EPS for the current year.
Maximus Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Sunday, August 31st. Stockholders of record on Friday, August 15th will be issued a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 1.4%. The ex-dividend date of this dividend is Friday, August 15th. Maximus's payout ratio is 22.10%.
Analyst Upgrades and Downgrades
Several research firms have weighed in on MMS. Wall Street Zen downgraded shares of Maximus from a "buy" rating to a "hold" rating in a research note on Thursday, May 15th. Zacks Research upgraded Maximus from a "hold" rating to a "strong-buy" rating in a report on Tuesday, August 26th. One research analyst has rated the stock with a Strong Buy rating and one has issued a Buy rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Strong Buy" and a consensus target price of $90.00.
Read Our Latest Stock Analysis on MMS
Maximus Company Profile
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Recommended Stories

Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.